In this episode, Dr. Donna Wilcock gives us some background on her research interests, her academic history, and discusses her latest work with biomarkers. In the context of unlocking the neuropathology of Alzheimer’s disease and related dementia (ADRD), biomarkers are becoming critical as they highlight potential areas for both areas of interest within the brain and for developing potential intervention strategies. For further reading, Dr. Wilcock suggests https://www.alzforum.org/news/conference-coverage/scientists-say-late-worsens-cognitive-decline https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00361-6/fulltext and https://markvcid.partners.org
